HOME >> BIOLOGY >> NEWS
Molecular probes for biology research and drug discovery

d have access to the complete genetic information of not only humans, but also of model organism like the mouse and rat. Also, the genetic information present in important nutrition plants like beans and rice is known. However, to make the promises of the genetics research reality, it is required that biology and chemistry form an alliance", says Herbert Waldmann, director at the Max Planck Institute for Molecular Physiology and coordinator for this multi-institute-spanning initiative of the Max Planck Society. "The CGC is currently the most important research initiative in its field in Europe. Especially the participation of the pharmaceutical industry is unique and enables research projects, normally not pursuable by universities or research institutes."

The build-up of the centre is endorsed by the Max Planck Society with a total of 5 million euro for an initial period of 5 years. This should enable the instalment of several junior research groups and support the research activities at the participating institutes. Furthermore pharmaceutical companies will participate as funding and research partners, financing additional research groups. All research groups will be hosted in the new labs of the Biomedical Centre Dortmund, in the immediate vicinity of the Max Planck Institute for Molecular Physiology.

The research groups supported by the companies will perform basic research on new, currently not sufficiently explored, areas for which, however, great potential for drug development is foreseeable. An example could be the pharmacologically oriented investigation in the interactions between proteins involved in the signal transduction pathways in the cell, leading to new approaches to modulate these interactions.

"The CGC creates a dynamic and inspiring research environment for all participants", states Herbert Waldmann. "Research will start in the summer of 2005 and it is already predictable that this will lead to very interesting a
'"/>

Contact: Dr. Herbert Waldmann
herbert.waldmann@mpi-dortmund.mpg.de
49-231-133-2400
Max-Planck-Gesellschaft
26-Jan-2005


Page: 1 2 3 4 5

Related biology news :

1. Molecular detectors may refine cancer treatment
2. Story ideas from Molecular & Cellular Proteomics
3. 2007 Image of the Year: Molecular imaging relates human brain chemistry to aggressive behavior
4. Molecular motors may speed nutrient processing
5. Molecular rendezvous caught on camera
6. Molecular tools make the cut
7. Genomatix and Molecular Connections form strategic partnership
8. Molecular motors and brakes work together in cells
9. Molecular link between inflammation and cancer discovered
10. Molecular on/off switch controls immune defenses against viruses
11. Molecular marker on stem cells aids research, perhaps therapies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced a ... Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of ... a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions ... as MediVet Biologics since its formation in 2016, the company is relaunching itself under ... build on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... CAMBRIDGE, Mass. and SOMERSET, N.J (PRWEB) , ... ... ... a leading genome editing company, and Catalent, the leading global provider of advanced ... and consumer health products, today announced that they have entered into a strategic ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... After research ... The completion of a great surgery is only the beginning of a successful study, ... research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
Breaking Biology Technology:
Cached News: